CND Life Sciences Company Profile: Funding, Investors & Partnerships

CND Life Sciences

CND has launched the Syn-One Test™ to offer physicians and patients an accurate, evidence-based tool to help confirm a diagnosis of a synucleinopathy. And our mission has just begun.CND has launched the Syn-One Test™ to offer physicians and patients an accurate, evidence-based tool Show More

Alpha Score

57.6

Total Funding$ 49.10 M